Biogen Inc. stock slipped 1.55% to $177.11 on Thursday, marking the end of a two-day winning streak despite an overall positive market session. The broader markets performed well, with the S&P 500 Index rising 0.62% to close at 6,824.66 and the Dow Jones Industrial Average gaining 0.58% to reach 48,185.80. This underperformance by BIIB contrasts sharply with the broader index gains and the company's recent momentum, highlighting a disconnect between Biogen's specific performance and general market sentiment on that day. The article notes that shares of Biogen Inc. closed lower even though it was described as an all-around great trading session for the stock market. This suggests that investors may be holding back on buying the stock or reacting to factors not immediately evident in the provided text, such as upcoming earnings reports or specific news affecting Biogen but not covered in this snippet. The discrepancy between the company's individual drop and the overall market rise indicates sector-specific weakness or a temporary lack of buyer interest for Biogen compared to its competitors on that particular day. Data for the stock comes from intraday data provided by FACTSET, with historical and current end-of-day data also sourced from FACTSET. All quotes referenced in the text are in local exchange time, while real-time last sale data for U.S. stock quotes reflects trades reported through Nasdaq only. It is worth noting that intraday data may be delayed at least 15 minutes or longer depending on specific exchange requirements, which could influence the precise timing of the observed price movements for Biogen and other stocks during Thursday's trading session.